Copyright
        ©2014 Baishideng Publishing Group Inc. All rights reserved.
    
    
        World J Gastroenterol. Aug 14, 2014; 20(30): 10432-10439
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10432
    Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10432
        MiRNA as potential biomarkers and therapeutic targets for gastric cancer
    
    
    Vivian Yvonne Shin, Kent-Man Chu, Department of Surgery,  The University of Hong Kong,  Queen Mary Hospital,  Hong Kong,  China
    Author contributions:  Shin VY and Chu KM contributed to the writing of the manuscript.
Correspondence to:  Kent-Man Chu, Professor, Department of Surgery, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, China. chukm@hku.hk
Telephone:  +852-2255-4637 Fax: +852-2819-4221
Received: October 28, 2013
Revised: February 4, 2014
Accepted: April 27, 2014
Published online: August 14, 2014
Processing time: 293 Days and 22.7 Hours
    Revised: February 4, 2014
Accepted: April 27, 2014
Published online: August 14, 2014
Processing time: 293 Days and 22.7 Hours
    Core Tip
Core tip: This minireview summarized the most up-to-date important microRNAs (miRNAs) involved in tumor progression and development in gastric cancer. The potential use of miRNAs in the different areas of clinical settings is discussed.

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        